Ensuring pituitary patients have security of supply for their essential medicines and therapies: Westminster’s Commons Select Committee on Health and Social Care is conducting an inquiry into Brexit preparations for a possible No-Deal outcome on 29 March 2019.
Found 296 results. Showing Page 17 of 30
Congratulations to the winner of the Endocrine Nurse Award for 2019, Alison Milne, Endocrine Nurse Specialist at NHS Grampian’s JJR Macleod Centre for Diabetes and Endocrinology in Aberdeen.
The Research House is an independent Market Research agency and we have received information from them requesting help with a research study for Growth Hormone Deficiency patients.
SMC has accepted hydrocortisone granules for restricted use for the replacement therapy of adrenal insufficiency.
Over the past five years, and beyond, The Pituitary Foundation has organised many proactive campaigns covering a number of key issues for patients. Themes have included: supporting earlier diagnosis, health care professionals’ education, emergency care and issues around quality of life.
On the 23rd May 2018 The Pituitary Foundation organised a focus group of Acromegaly patients, around the holistic management of Acromegaly. Find out more here.
Mick tells us his experiences of being diagnosed with acromegaly.
August 2018 - Concordia International have given their latest update on the supplies of Hydrocortisone Sodium Phosphate (ex Efcortesol).
Diabetes Insipidus – time to change the name?
Advice for how diabetes insipidus patients should manage their symptoms in the hot summer weather.